BST/90B (BST/90B)

Stuttgart Stock Exchange: BST/90B · EUR

€6.70

+0.05 (+0.8%)· Recorded snapshot

Market cap	576.1M
Revenue (ttm)	75.4M
Net income (ttm)	-70.8M
EPS (ttm)	-€1.04

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 75.4M
Net income (ttm): -70.8M
EPS (ttm): -€1.04
Market cap: 576.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-101.2

P25 n/aP50 n/aP75 n/a

ROIC-32.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BST/90B indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Switzerland
Country code	DE
Earnings date	2026-11-03
Employees	415
Employees change	-8
Employees growth	-1.89%
Enterprise value	EUR 534.9M
Exchange	Stuttgart Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-19
Fiscal year end	December
Founded	2011
Industry	Health Information Services
Is primary listing	No
ISIN number	CH1125843347
Last refreshed	2026-10-28
Market cap	EUR 576.1M
Next earnings date	2026-11-03
Price	EUR 6.70
Price currency	EUR
Sector	Healthcare
SIC code	7370
Stock price date	2026-10-27
Symbol	bst/90B
Website	https://www.sophiagenetics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-15.57%
EV/Sales	6.92x
FCF / EV yield	-6.74%
FCF yield	-6.26%
P/B ratio	7.92x
P/S ratio	7.64x
Price / tangible book value	14.02x
Sector forward P/E	14.84x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-85.58%
EBITDA margin	-83.26%
Gross margin	66.63%
Operating margin	-85.58%
Pretax margin	-93.19%
Profit margin	-93.86%
Profit per employee	EUR -170,584
Revenue per employee	EUR 181,740
ROA	-24.52%
ROA (5Y)	-22.17%
ROCE	-50.07%
ROE	-101.22%
ROE (5Y)	-56.26%
ROIC	-32.29%
SBC / revenue	18.36%
Tax / revenue	0.67%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	21.54%
Gross profit growth (Q)	22.75%
Gross profit growth 3Y	16.12%
Gross profit growth 5Y	22.27%
Net income growth quarters	1
Net income growth years	0
Revenue growth	23.65%
Revenue growth (Q)	27.22%
Revenue growth (QoQ)	7.48%
Revenue growth 3Y	16.82%
Revenue growth 5Y	20.33%
Revenue growth quarters	7
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.3M
Depreciation and amortization	EUR 1.8M
EBIT	EUR -64.5M
EBITDA	EUR -62.8M
EPS	EUR -1.04
Financing cash flow	EUR 56.6M
Free cash flow	EUR -36.1M
Free cash flow minus SBC	EUR -49.9M
Gross profit	EUR 50.3M
Income taxes	EUR 505,923
Investing cash flow	EUR -9.7M
Net borrowing	EUR -2M
Net cash flow	EUR 11.2M
Net income	EUR -70.8M
Operating cash flow minus SBC	EUR -48.6M
Operating income	EUR -64.5M
Revenue	EUR 75.4M
Stock-based compensation	EUR 13.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.61
Book value per share	EUR 0.85
Debt / equity	0.74
Interest coverage	-11.13
Long-term assets	EUR 50.2M
Long-term liabilities	EUR 54.9M
Net cash (debt)	EUR 40.1M
Net cash / market cap	6.96%
Net cash growth	47.82%
Net debt / equity	-0.55
Piotroski F-Score	2
Property, plant and equipment	EUR 14.3M
Shareholders' equity	EUR 72.8M
Tangible book value	EUR 41.1M
Tangible book value per share	EUR 0.48
Total assets	EUR 173.6M
Total cash	EUR 94.2M
Total debt	EUR 54.1M
Total liabilities	EUR 100.9M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.46
Current assets	EUR 123.5M
Current liabilities	EUR 45.9M
Current ratio	2.69
Inventory turnover	4.32
Net working capital	EUR -16.4M
Quick ratio	2.38
Working capital	EUR 75.5M
Working capital turnover	0.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.4%
Shareholder yield	-4.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 5.41
1D price change	0.75%
1M price change	-7.59%
1M total return	-7.59%
1W price change	8.94%
1W total return	8.94%
1Y price change	81.08%
1Y return CAGR	81.16%
1Y total return	81.08%
20-day SMA	EUR 6.53
200-day SMA	EUR 5.08
3M price change	34%
3M total return	34%
3Y price change	84.07%
3Y return CAGR	22.55%
3Y total return	84.07%
50-day SMA	EUR 6.86
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 7.60
52-week high date	2026-08-28
52-week low	EUR 3.34
52-week low date	2025-11-21
6M price change	63.42%
6M total return	63.42%
All-time high	EUR 7.60
All-time high date	2026-08-28
All-time low	EUR 2.08
All-time low date	2023-08-18
Average true range (ATR)	EUR 0.23
Average volume	0
Change from 52-week high	-11.84%
Change from 52-week low	100.6%
Change from all-time high	-11.84%
Change from all-time low	222.12%
Monthly RSI	63.34
Previous close	EUR 6.65
Price vs 150-day SMA	23.89%
Price vs 20-day SMA	2.6%
Price vs 200-day SMA	31.99%
Price vs 50-day SMA	-2.3%
RSI	52.4
Sharpe ratio	1.21
Sortino ratio	2.43
Weekly RSI	59.12
YTD price change	72.68%
YTD total return	72.68%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65.5M
Shares change (QoQ)	3.8%
Shares change (YoY)	4.4%
Shares held by insiders	8.4%
Shares held by institutions	47.74%
Short ratio	1.7 days

Deeper analysis on BST/90B

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BST/90B report

Is a complete BST/90B research report available?

No complete published report is available for bst/90B (BST/90B) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BST/90B (BST/90B)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/90B

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BST/90B indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/90B

Frequently asked questions